Home Feature Archives - UNC Lineberger Comprehensive Cancer Center

Gloved hands carefully handling a blood sample in a medical laboratory environment.

UNC Lineberger is recruiting participants for the Vanguard Study, which is evaluating a new type of blood test that screens for several types of cancer. This is the first study of the Cancer Screening Research Network.

Drs. Barbara Savoldo, Gianpietro Dotti, Robert L. Ferris, Natalie Grover and Jonathan S. Serody at the UNC Health Foundation’s Game Changers event on November 4, 2025

This gift will fuel the next generation of cancer treatments, supporting all aspects of the UNC Lineberger Cellular Immunotherapy Program with an emphasis on clinical trials, expansion of the cellular therapeutics facility, and faculty recruitment and retention.

Collage of images from the symposium, including presenters and attendees.

The 49th Annual UNC Lineberger Scientific Symposium focused on emerging discoveries in RNA biology and their potential to advance cancer research and treatment. The event also featured a poster session and the inaugural Earp Lecture, a new endowed lectureship.

The PSA test is commonly used as a tumor marker to screen for and monitor prostate cancer.

The grant will support Check & Protect: UNC Prostate Cancer Awareness and Screening Initiative, a community‑based pilot program designed to expand prostate cancer education, screening and early detection among men at increased risk.

Radiologist showing tomography scan of a patient's lungs over of CT machine.

To better understand the burdens of false-positive lung cancer screenings and ways to mitigate them, the NCI awarded UNC Lineberger researchers a $3.2 million grant to identify the potential harms of false-positive results at the patient, clinician, and facility levels.

Attendees at a keynote session for the UNC Lineberger Data Science Symposium.

Researchers, clinicians, data scientists and trainees gathered for the inaugural UNC Lineberger Innovate Cancer Data Science Symposium, a daylong event highlighting the rapid evolution of AI, genomics and data‑driven tools shaping the future of cancer care.

Group shot of UNC Lineberger Community Advisory Board members.

UNC Lineberger’s Community Advisory Board works to make sure cancer research reflects community needs across the state, and to raise public awareness of cancer’s signs and symptoms.

Illustration of a cancer cell with a target highlighted over the cell.

UNC Eshelman School of Pharmacy’s Chemical Biology and Medicinal Chemistry Division is a central hub for cancer therapeutics. Its faculty members are studying the chemical and biological mechanisms that promote cancer growth and persistence.

Patients using smartphones, tablets and laptops to report symptoms.

Digital reporting technologies created by UNC Lineberger researchers are now being used in North Carolina and across the country to improve care and outcomes for cancer patients.

Group shot of all attendees of the 2025 Trainee Research Day.

The 50th annual UNC Lineberger Trainee Research Day bought together graduate students and postdoctoral research associates to share their work with peers and faculty, and to hear valuable career advice from former postdoctoral fellows.

Tag: Home Feature

UNC Lineberger launches study to evaluate multi-cancer detection tests

Transformational $20 million commitment will support UNC Lineberger’s Cellular Immunotherapy Program

Scientific symposium highlights advances in RNA research and cancer therapeutics

UNC Lineberger receives ZERO Prostate Cancer grant to expand prostate cancer screening in rural North Carolina

Investigating approaches to make lung cancer screening more effective

UNC Lineberger hosts inaugural Innovate Cancer Data Science Symposium

Community Advisory Board engages NC communities in the fight against cancer

Priming the pump for new cancer treatments

Building tools to help doctors better track patient symptoms, improve outcomes

Trainee Research Day celebrates 50 years of science, honors top research